Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1998
08/18/1998US5795964 Of specified amino acid sequences; antiinflammatory and antitumor agents
08/18/1998US5795958 Library of glyco-peptides useful for identification of cell adhesion inhibitors
08/18/1998US5795957 Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
08/18/1998US5795954 Factor VIIa inhibitors from Kunitz domain proteins
08/18/1998US5795908 Fkbp immunophilins for enzyme inhibitors
08/18/1998US5795896 Consisting of thrombin inhibitor and absorption inhibiting agent
08/18/1998US5795882 Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
08/18/1998US5795877 Inhibitors of NAALADase enzyme activity
08/18/1998US5795868 Platelet aggregation inhibitors
08/18/1998US5795867 Platelet aggregation inhibitors
08/18/1998US5795866 ETS1 gene: a human tumor suppressor gene
08/18/1998US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
08/18/1998US5795864 Stable omega conopetide formulations
08/18/1998US5795863 Recombinant agents affecting thrombosis
08/18/1998US5795862 Ectoparasite saliva proteins and apparatus to collect such proteins
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795860 Analogs for specific oligosaccharide-protein interactions and uses therefor
08/18/1998US5795859 Peptide which abrogates TNF and/or LPS toxicity
08/18/1998US5795858 Treatment or prevention of Crohn's disease and/or ulcerative colitis
08/18/1998US5795779 Human interferon-β (IFN-β) produced in Chinese hamster ovary (CHO) cells
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795768 Genetic engineering
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795757 DNA encoding threonyl tRNA synthetase from staphylococcus aureus
08/18/1998US5795745 Human growth hormone
08/18/1998US5795740 Pituitary differentiation factor and methods of use thereof
08/18/1998US5795736 Peptide amino acid sequences, replacements and expression vectors
08/18/1998US5795735 Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly
08/18/1998US5795734 Tyrosine kinases, cell differentiation
08/18/1998US5795726 Methods for identifying compounds useful in treating type II diabetes
08/18/1998US5795724 Human N-acetyl transferase
08/18/1998US5795723 Measuring transcripts or proteins expresedfrom genes
08/18/1998US5795579 Herpes simplex virus VP16 vaccines
08/18/1998US5795577 Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.
08/18/1998US5795572 Monoclonal antibodies and FV specific for CD2 antigen
08/18/1998US5795571 Coagulation
08/18/1998US5795569 Polypeptides
08/18/1998US5795568 Method of treating infectious disease with GM-CSF
08/18/1998US5795489 Separation of particles from liquid, rotation and filtration
08/18/1998CA2215920A1 Drug binding protein
08/18/1998CA2131455C Selective crosslinking of hemoglobin by oxidized, ring-opened saccharides
08/18/1998CA1340007C Linear analogs of atrial natruiretic peptides
08/18/1998CA1340006C Acylated cyanamide composition
08/18/1998CA1340005C Pharmaceutical composition for the treatment of psoriasis
08/13/1998WO1998035061A2 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998WO1998035056A1 Identification of inhibitors of protein tyrosine kinase 2
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998035045A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
08/13/1998WO1998035043A1 Human sdf-5 protein and compositions
08/13/1998WO1998035042A2 Activity dependent neurotrophic factor iii (adnf iii)
08/13/1998WO1998035041A1 Human lea-motif developmental protein
08/13/1998WO1998035040A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
08/13/1998WO1998035039A1 Dendritic cell-derived growth factor
08/13/1998WO1998035038A1 Human dosage compensation-associated protein
08/13/1998WO1998035036A1 Heregulin variants
08/13/1998WO1998035035A1 Novel mouse cxc chemokine receptor
08/13/1998WO1998035034A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998WO1998035032A2 Methods of inducing cell cycle stasis
08/13/1998WO1998035028A2 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998WO1998035020A2 Methods for modulating hematopoiesis and vascular growth
08/13/1998WO1998035014A2 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom
08/13/1998WO1998034957A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE α-GALACTOSYL EPITOPE
08/13/1998WO1998034955A1 No-modified hemoglobins and uses therefor
08/13/1998WO1998034954A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998WO1998034952A2 Il-2 gene expression and delivery systems and uses
08/13/1998WO1998034951A1 A new cytokine family and uses thereof
08/13/1998WO1998034950A1 Isolated candida albicans oligopeptide transporter gene
08/13/1998WO1998034949A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
08/13/1998WO1998034946A1 Daxx, a novel fas-binding protein that activates jnk and apoptosis
08/13/1998WO1998034945A1 Targeted modification of the ccr-5 gene
08/13/1998WO1998034910A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/13/1998WO1998034667A1 Gene therapeutic treatment of blood vessel associated disorders
08/13/1998WO1998034655A1 Matrix-free osteogenic devices, implants and methods of use thereof
08/13/1998WO1998034642A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
08/13/1998WO1998034641A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998034638A1 Maspin inhibition of tpa activity
08/13/1998WO1998034637A1 Use of a polypeptide for obtaining a composition for detecting, preventing or treating a degenerative and/or autoimmune disease
08/13/1998WO1998034636A1 Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
08/13/1998WO1998034635A1 Methods and compositions for the inhibition of interleukin-12 production
08/13/1998WO1998034634A1 Compositions and methods for inhibiting cellular proliferation
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034631A1 Peptide mimetics of the cytokine receptor gamma chain
08/13/1998WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
08/13/1998WO1998034624A1 Use of the p-ten suppressor gene in diagnosis and treatment of cancer
08/13/1998WO1998034590A1 Active composition for combating the effects of the cold and cosmetic product containing this composition
08/13/1998WO1998030709A3 Non-immunogenic prodrugs and selectable markers for use in gene therapy
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998027980A3 Method of producing a sustained-release preparation
08/13/1998WO1998025965A3 Peptides and compounds that bind to the thrombopoietin receptor
08/13/1998WO1998024888A3 Polypeptides encoded by a human lipase-like gene, compositions and methods
08/13/1998WO1998024808A3 Inhibition of IgE-mediated allergies by a human IgE-derived oligopeptide
08/13/1998WO1998023750A3 Mammalian chemokines
08/13/1998WO1998022501A3 Secreted proteins and polynucleotides encoding them
08/13/1998WO1998019670A3 Combination therapy of hepatitis C infections
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998WO1998007851A3 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
08/13/1998WO1998004290A3 Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
08/13/1998CA2281792A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
08/13/1998CA2281699A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
1 ... 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 ... 3163